Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cresco Labs Inc
(OP:
CRLBF
)
0.9396
-0.0204 (-2.12%)
Streaming Delayed Price
Updated: 3:59 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cresco Labs Inc
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
420 with CNW — Reports Indicate DEA Didn’t Support Marijuana Reclassification
May 31, 2024
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
Top Ohio Cannabis Companies: Analyst Look At Stocks With Potential Market Cap Gains
May 30, 2024
How will Ohio's cannabis market shape up as it transitions to adult-use recreational sales? Senior analyst Pablo Zuanic outlines in his recent report the potential growth and value creation for state...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CRLBF Stock Earnings: Cresco Labs Meets EPS, Beats Revenue for Q1 2024
May 29, 2024
CRLBF stock results show that Cresco Labs met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
DEA Rules THCA Is Not Legal Hemp Amid Industry Shake-Up And Farm Bill Debate On Delta-8 THC Prohibition
May 28, 2024
DEA rules THCA not legal hemp, sparking industry concerns. Congress debates Farm Bill changes. Curaleaf criticizes amendment. Read now!
Via
Benzinga
All 12 Constituents In The Cannabis Portfolios Declined W/e May 24th
May 27, 2024
All 12 constituents declined w/e by an average of 14.4% and are now down 28.9%, on average, since Tuesday, April 30th, when the DEA announced it planned to reclassify cannabis as a less regulated...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
The 2024 Millionaire’s Club: 7 Cannabis Stocks to Buy Now
May 26, 2024
One of the hottest topics of the year has been cannabis stocks to buy, especially with elections nearing. Here are seven to consider.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
House Committee Approval Of Amendment Eliminating 90% Of Hemp-Dervied Products Could Drive Wedge Between Cannabis And Hemp Industries
May 24, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
3 Cannabis Stocks That Could Be Millionaire-Makers: May Edition
May 22, 2024
Cannabis stocks to buy are surging after the DOJ proposed reclassifying marijuana, signaling a promising future.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks And ETFs Surged On Marijuana Rescheduling News: WTR's Industry Report Analyzes What's Behind The Optimism
May 21, 2024
DOJ proposes reclassifying cannabis to Schedule III. WTR's report highlights market gains and potential industry impacts. Read insights now!
Via
Benzinga
Topics
Cannabis
ETFs
Exposures
Cannabis
American Cannabis MSOs Portfolio Reversed Direction Last Week
May 19, 2024
This article highlights how each constituent in the Portfolio fared last week and MTD along with their reported Q1 profit or loss and their Q1 adjusted EBITDA as a percentage of quarterly revenue for...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
All Cresco Labs' QI Financial Metrics Down Except SG&A
May 15, 2024
Despite the poor Q1 financial report Cresco's stock price is UP 2.5% as of mid-day but is still DOWN 1.9% from last Friday albeit UP 52.6% YTD.
Via
Talk Markets
Officials Highlight Areas of Failure as Cannabis Program in New York Is Overhauled
May 15, 2024
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
Cresco Labs CEO Touts 10x Increase In Operating Cash Flow YoY As Cannabis Company Reports Q1 Results
May 15, 2024
Cannabis producer Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) announced on Wednesday its financial and operating results for the first quarter ended March 31, 2024. "I want to thank the Cresco...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results
May 15, 2024
From
Cresco Labs
Via
Business Wire
Florida Cannabis Legalization Amendment Ads Hit Airwaves: The First 4 Pitches For Legal Weed In The Sunshine State
May 14, 2024
The advocacy group's ads are being aired across the state over TV, radio, streaming and on digital sites. Having spent more than $5 million, the ads are criss-crossing the state to bring attention to...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The 7 Most Undervalued Cannabis Stocks to Buy in May 2024
May 13, 2024
Some of the most undervalued cannabis stocks could race to higher highs on several key catalysts this year. Here are seven.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
American Cannabis MSOs Portfolio Down 5% On The Week
May 11, 2024
Five of the 7 constituents released their Q1 financial reports earlier this week, contributing to a 5% decline in our portfolio for the week ending May 10.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Shhh! 3 Secret Penny Stocks Flying Below Wall Street’s Radar
May 09, 2024
Under-the-radar penny stocks can be some of the most rewarding investments on the market. Here are three to consider.
Via
InvestorPlace
Curaleaf Reports 16% Reduction In Net Loss In Q1 Financial Report
May 09, 2024
Curaleaf has evolved from an MSO to an MCO, a multi-country operator, doing business in 15 countries worldwide with the expectation of creating further separation from their peers.
Via
Talk Markets
Medical Marijuana Giant Trulieve, Backer Of Florida's Recreational Cannabis Ballot, Narrows Loss, Reports Uptick In Q1 Revenue, Gross Profit
May 09, 2024
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahassee, Florida-based medical cannabis giant reported revenue of $298 million...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cresco Labs Announces May Conference Participation
May 09, 2024
From
Cresco Labs
Via
Business Wire
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
May 08, 2024
These top cannabis stocks by revenue are among the world's best sellers, making them prime investment opportunities to capture legal changes.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
420 with CNW — US Cannabis Companies Could Soon Access Bankruptcy Protection
May 08, 2024
Via
CannabisNewsWire
Topics
Bankruptcy
Cannabis
Exposures
Cannabis
Financial
Legal
Marijuana Stock Movers For May 7, 2024
May 07, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Workers In L.A. Join Teamsters To Improve Pay, Working Conditions And Have A Voice
May 07, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Big Players In U.S. Cannabis Could Play The Stock-Value Card In M&A, New Report Shows
May 06, 2024
As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Monday For Marijuana Stocks - Target Group, Item 9 Labs Among Top Gainers
May 06, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Dropped 19%, On Average, In Last 3 Days Of This Week
May 04, 2024
The cannabis sector dropped 18.8% in the last 3 days and it probably has further to go, based on historical data.so the question now is how much further it will drop before stabilizing. Time will tell....
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Wall Street Analysts Predict 1000% Upside for These 7 Penny Stocks
May 04, 2024
Despite higher interest rates, if you have a long-term view, it’s a good time to watch for some penny stocks with upside potential.
Via
InvestorPlace
Credit Check: What Does DEA Rescheduling Mean For Cannabis Credit Ratings? Big Companies' Risk-Return Profiles
May 03, 2024
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations of multi-state operators (MSOs).
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
...
36
37
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.